RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: pancreatic ductal carcinoma
Accession: DOID:3587
browse the term
Definition: A pancreatic carcinoma located_in the pancreatic duct. (DO)
Synonyms: exact_synonym: Duct Cell Carcinoma of the Pancreas; Pancreas Duct-Cell Carcinoma; Pancreas Duct-Cell Carcinomas; Pancreatic Ductal Carcinomas; ductal carcinoma of the pancreas; malignant neoplasm of duct of Wirsung; pancreatic duct cancer; pancreatic duct cell carcinoma
primary_id: MESH:D021441
xref: ICD10CM:C25.3 ; ICD9CM:157.3
For additional species annotation, visit the
Alliance of Genome Resources .
G
Ace
angiotensin I converting enzyme
ISO
mRNA, protein:increased expression:pancreas
RGD
PMID:17481528
RGD:2325211
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
ISO
protein:decreased expression:pancreas
RGD
PMID:19212105
RGD:2325210
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Adam8
ADAM metallopeptidase domain 8
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:17979891
RGD:2325243
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adam9
ADAM metallopeptidase domain 9
disease_progression
ISO
protein:altered localization:cytoplasm
RGD
PMID:14997207
RGD:2325249
NCBI chr16:73,725,186...73,804,284
Ensembl chr16:67,022,655...67,100,917
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
ISO
mRNA:increased expression:pancreas
RGD
PMID:19609859
RGD:2325659
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Agtr1a
angiotensin II receptor, type 1a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Alb
albumin
disease_progression
ISO
RGD
PMID:19011933
RGD:2325677
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Anxa2
annexin A2
disease_progression
ISO
mRNA, protein:increased expression, altered localization:pancreas, plasma membrane
RGD
PMID:19260470 PMID:16450333
RGD:2317307 , RGD:2325731
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:70,105,253...70,141,658
G
Anxa5
annexin A5
ISO
protein:increased expression:pancreas
RGD
PMID:19488907
RGD:2317538
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:119,314,007...119,353,369
G
Anxa8
annexin A8
ISO
mRNA:increased expression:pancreas
RGD
PMID:18223320
RGD:2325735
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
G
Apoc1
apolipoprotein C1
ISO
RGD
PMID:15876873
RGD:2325793
NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:79,346,136...79,350,375
G
Arg2
arginase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23424623
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:97,936,002...97,961,378
G
Bmi1
BMI1 proto-oncogene, polycomb ring finger
ISO
protein:increased expression:pancreas protein:increased expression:exocrine pancreas:
RGD
PMID:19585519 PMID:19585519
RGD:9491843 , RGD:9491843
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
G
C1h19orf33
similar to human chromosome 19 open reading frame 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35142956
NCBI chr 1:84,549,830...84,550,666
Ensembl chr 1:84,549,831...84,550,664
G
Calr
calreticulin
ISO
protein:increased expression:pancreatic duct
RGD
PMID:15289361
RGD:2326165
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Cbx7
chromobox 7
disease_progression
ISO
protein:decreased expression:pancreas
RGD
PMID:20185297
RGD:9587360
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Cckar
cholecystokinin A receptor
ISO
mRNA:increased expression:pancreatic duct protein:decreased expression:pancreas
RGD
PMID:9239407 PMID:12851875
RGD:4110818 , RGD:4110816
NCBI chr14:61,505,270...61,513,618
Ensembl chr14:57,292,397...57,300,747
G
Cckbr
cholecystokinin B receptor
ISO
protein:decreased expression:pancreas
RGD
PMID:12851875
RGD:4110816
NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:159,771,733...159,814,881
G
Ccnd1
cyclin D1
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:17420962
RGD:13462063
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Cd40
CD40 molecule
treatment
ISO
protein:increased expression:dendritic cell
RGD
PMID:21436454 PMID:23983255 PMID:20976171
RGD:5490301 , RGD:11522743 , RGD:5490524
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cdk6
cyclin-dependent kinase 6
treatment
ISO
human cells in a mouse model
RGD
PMID:24389175
RGD:13782187
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:17671118
RGD:8662851
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24986516
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cldn4
claudin 4
ISO
RGD
PMID:15693851
RGD:2317592
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:21,751,331...21,753,436
G
Cxcl11
C-X-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Dnmt1
DNA methyltransferase 1
disease_progression
ISO
protein:increased expression:pancreas CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29844410 PMID:19424621
RGD:9588974
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3b
DNA methyltransferase 3 beta
disease_progression
ISO
RGD
PMID:22919364
RGD:9589121
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
Dtx1
deltex E3 ubiquitin ligase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr12:35,849,647...35,880,835
Ensembl chr12:35,849,617...35,880,838
G
Dtx4
deltex E3 ubiquitin ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
G
Egf
epidermal growth factor
disease_progression
ISO
protein:increased expression: :
RGD
PMID:18505086
RGD:2317644
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Faslg
Fas ligand
ISO
protein:increased expression:pancreas, liver
RGD
PMID:10547193 PMID:15375495
RGD:2317747 , RGD:2317741
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fgf2
fibroblast growth factor 2
disease_progression
ISO
RGD
PMID:12717266 PMID:18704599
RGD:2317758 , RGD:2317756
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fscn1
fascin actin-bundling protein 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:12109856
RGD:2317790
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Gpnmb
glycoprotein nmb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gstp1
glutathione S-transferase pi 1
resistance
ISO
DNA:methylation: : mRNA, protein:increased expression:pancreas
RGD
PMID:16537562 PMID:12488200 PMID:17265526
RGD:2317809 , RGD:2317811 , RGD:2317806
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hdac1
histone deacetylase 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:19424621
RGD:9588974
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
G
Heatr1
HEAT repeat containing 1
treatment
ISO
RGD
PMID:26676747
RGD:10761108
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
G
Hes1
hes family bHLH transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:93,095,498...93,100,312
G
Hey2
hes-related family bHLH transcription factor with YRPW motif 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 1:28,641,100...28,651,187
Ensembl chr 1:26,822,131...26,832,218
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234771
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234771
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Igf1
insulin-like growth factor 1
ISO
RGD
PMID:20098680
RGD:2317639
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
ISO
protein:increased expression:pancreas
RGD
PMID:14627343 PMID:14506643
RGD:2317649 , RGD:2317652
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Il4
interleukin 4
ISO
RGD
PMID:17942922
RGD:2317264
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
ISO
protein:increased expression:pancreas
RGD
PMID:17942922
RGD:2317264
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980
G
Ins2
insulin 2
ISO
Glucagon/insulin
RGD
PMID:19571666
RGD:2317248
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775
G
Jag1
jagged canonical Notch ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:124,406,794...124,442,209
G
Jag2
jagged canonical Notch ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818
G
Kdm2b
lysine demethylase 2B
severity
ISO
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:23321669
RGD:9588253
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25347530 PMID:30654191
NCBI chr 4:179,916,255...179,949,613
G
Krt7
keratin 7
disease_progression
ISO
RGD
PMID:19260470
RGD:2317307
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
L1cam
L1 cell adhesion molecule
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:20162456
RGD:6483447
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:151,597,277...151,623,857
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mapk3
mitogen activated protein kinase 3
treatment
ISO
human cells in mouse model
RGD
PMID:20179210
RGD:14348973
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mcm7
minichromosome maintenance complex component 7
ISO
mRNA, protein:increased expression:pancreatic duct
RGD
PMID:15548371
RGD:2317697
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mdm2
MDM2 proto-oncogene
onset severity
ISO
DNA:snp:promoter, intron:IVS1+309T>G (human) protein:increased expression:pancreas (human)
RGD
PMID:19752772 PMID:15810085
RGD:2317414 , RGD:2317416
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Men1
menin 1
ISO
protein:decreased expression:pancreas
RGD
PMID:19170121
RGD:2317294
NCBI chr 1:213,068,166...213,074,132
Ensembl chr 1:203,639,000...203,644,871
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
protein:increased expression:pancreatic duct (human)
RGD
PMID:7866999
RGD:2317530
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mgmt
O-6-methylguanine-DNA methyltransferase
susceptibility
ISO
DNA:missense mutation:cds:p.L84F rs12917 (human) protein:increased activity, increased expression:ductal adenocarcinoma (human)
RGD
PMID:16844323 PMID:9393761
RGD:2317648 , RGD:2317664
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:191,710,930...191,937,756
G
Mir142
microRNA 142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr10:73,055,104...73,055,190
Ensembl chr10:72,557,857...72,557,967
G
Mir873
microRNA 873
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30654191
NCBI chr 5:51,356,919...51,356,995
Ensembl chr 5:51,356,919...51,356,995
G
Mmp2
matrix metallopeptidase 2
severity
ISO
protein:increased expression:pancreas
RGD
PMID:17377415
RGD:2325746
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:pancreas, serum protein:increased expression:blood
RGD
PMID:18706098 PMID:20332475
RGD:2325844 , RGD:2325830
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Msln
mesothelin
disease_progression
ISO
protein:increased secretion:serum DNA:hypomethylation:5'UTR CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14576474 PMID:21775916 PMID:25347530 PMID:19818733 PMID:12874021
RGD:2326055 , RGD:2326065
NCBI chr10:15,276,489...15,285,921
Ensembl chr10:14,771,961...14,777,643
G
Muc1
mucin 1, cell surface associated
disease_progression
ISO
protein:increased expression, altered localization:pancreas
RGD
PMID:14681945 PMID:18713982 PMID:19109152
RGD:2317983 , RGD:2324633 , RGD:2324616
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Muc17
mucin 17, cell surface associated
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:12657964
RGD:2324946
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
G
Muc3a
mucin 3A, cell surface associated
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:12657964
RGD:2324946
NCBI chr12:19,450,679...19,454,753
Ensembl chr12:19,446,094...19,460,522
G
Muc4
mucin 4, cell surface associated
disease_progression
ISO
mRNA:increased expression:pancreas protein:increased expression:pancreas
RGD
PMID:12657964 PMID:16049287
RGD:2324946 , RGD:2324942
NCBI chr11:68,008,245...68,053,242
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:7657125 PMID:10227724
RGD:2324986 , RGD:2324907
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
ISO
mRNA:increased expression:pancreas
RGD
PMID:7657125
RGD:2324986
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Ndrg1
N-myc downstream regulated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16778198
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489257
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
ISO
protein:increased expression:pancreas (human)
RGD
PMID:17492507
RGD:5132867
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:78,906,083...78,916,408
G
Nos2
nitric oxide synthase 2
ISO
RGD
PMID:12660813
RGD:2325254
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19208345 PMID:20484026 PMID:19028876
RGD:2325323 , RGD:2325324
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Notch3
notch receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,133,706...11,184,025
G
Notch4
notch receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr20:4,164,969...4,189,072
Ensembl chr20:4,160,445...4,184,465
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:11295066 PMID:10209957
RGD:2325660 , RGD:2325663
NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:132,132,849...132,503,286
G
Osm
oncostatin M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr14:83,327,202...83,332,073
Ensembl chr14:79,104,344...79,108,313
G
Palld
palladin, cytoskeletal associated protein
ISO
protein:increased expression, alternative form:pancreas, fibroblast
RGD
PMID:17404500
RGD:2325781
NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337
G
Pax6
paired box 6
ISO
protein:increased expression:pancreatic duct (human)
RGD
PMID:17849422
RGD:8552381
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:92,135,637...92,157,014
G
Pms1
PMS1 homolog 1, mismatch repair system component
ISO
protein:increased expression:pancreatic duct
RGD
PMID:15856462
RGD:2324870
NCBI chr 9:55,721,393...55,832,225
Ensembl chr 9:48,253,410...48,340,237
G
Pparg
peroxisome proliferator-activated receptor gamma
disease_progression
ISO
RGD
PMID:19396032
RGD:2317461
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:18670639
RGD:2317185
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rnf2
ring finger protein 2
ISO
protein:increased expression:pancreas
RGD
PMID:19585519
RGD:9491843
NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099
G
Rxra
retinoid X receptor alpha
severity
ISO
RGD
PMID:19396032
RGD:2317461
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
Serpina1
serpin family A member 1
ISO
mRNA, protein:increased expression:pancreas
RGD
PMID:12488200
RGD:2317811
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:122,866,312...122,888,339
G
Slc2a2
solute carrier family 2 member 2
ISO
protein:increased expression:pancreatic duct
RGD
PMID:19252908
RGD:2324975
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933
G
Smad4
SMAD family member 4
disease_progression
ISO
RGD
PMID:15173084
RGD:21066334
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Smo
smoothened, frizzled class receptor
ISO
RGD
PMID:16826192
RGD:2324981
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:58,343,529...58,373,829
G
Stk11
serine/threonine kinase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26887594
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:9,575,269...9,591,315
G
Tgfb1
transforming growth factor, beta 1
disease_progression
ISO
RGD
PMID:16101174
RGD:2325019
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr2
transforming growth factor, beta receptor 2
disease_progression
ISO
mRNA:increased expresssion:pancreas
RGD
PMID:17114585 PMID:10547197
RGD:2317498 , RGD:2317500
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:115,794,537...115,883,228
G
Thbs1
thrombospondin 1
disease_progression
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:12429967 PMID:19065635
RGD:2325025 , RGD:2325022
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Tmprss3
transmembrane serine protease 3
ISO
RGD
PMID:14695172
RGD:2325152
NCBI chr20:9,254,102...9,273,808
Ensembl chr20:9,254,109...9,274,363
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tsc2
TSC complex subunit 2
severity
ISO
RGD
PMID:16213898
RGD:11568674
NCBI chr10:14,125,679...14,160,317
Ensembl chr10:13,621,136...13,655,951
G
Tymp
thymidine phosphorylase
disease_progression
ISO
RGD
PMID:19760965
RGD:2325155
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vhl
von Hippel-Lindau tumor suppressor
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:19065635
RGD:2325022
NCBI chr 4:148,328,099...148,334,992
Ensembl chr 4:146,772,468...146,779,377
G
Yeats2
YEATS domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr11:80,743,134...80,829,253
Ensembl chr11:80,743,134...80,829,208
G
Zzz3
zinc finger, ZZ-type containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 2:241,330,366...241,397,308
Ensembl chr 2:241,331,022...241,397,307
G
Tgfb2
transforming growth factor, beta 2
ameliorates
ISO
human cells in a mouse model
RGD
PMID:21366804
RGD:155630611
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
ISO
protein:increased expression:pancreas
RGD
PMID:19714807
RGD:2325658
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Akr7a2
aldo-keto reductase family 7, member A2
ISO
protein:increased expression:pancreas
RGD
PMID:19077459
RGD:2325696
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Calr
calreticulin
ameliorates
ISO
human cells in mouse model human cells in a mouse model
RGD
PMID:33028359 PMID:29072694
RGD:150520160 , RGD:150521706
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Ccnd1
cyclin D1
severity
ISO
DNA:snp:exon:c.870G>A (human) protein:increased expression:pancreas (human)
RGD
PMID:25470788 PMID:22939953
RGD:13462050 , RGD:13462062
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Cd59b
CD59b molecule
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:90,459,162...90,478,847
G
Cdk4
cyclin-dependent kinase 4
severity
ISO
protein:increased expression:pancreas, islet of Langerhans (human)
RGD
PMID:29735403
RGD:13781899
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
E2f1
E2F transcription factor 1
severity
ISO
protein:increased expression:pancreatic ductal cell, nucleus (human) DNA:amplification: : (human)
RGD
PMID:12650514 PMID:17233815 PMID:27573434
RGD:13838735 , RGD:13838739 , RGD:13838738
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
Foxm1
forkhead box M1
disease_progression
ISO
RGD
PMID:24859161
RGD:156430321
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Fubp1
far upstream element binding protein 1
ISO
mRNA:increased expression:pancreatic duct (human)
RGD
PMID:32481602
RGD:151361197
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:241,159,512...241,186,602
G
Glipr2
GLI pathogenesis-related 2
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 5:58,170,417...58,202,258
Ensembl chr 5:58,170,425...58,202,272
G
Got1
glutamic-oxaloacetic transaminase 1
treatment
ISO
human cells in a mouse model
RGD
PMID:23535601
RGD:13504844
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
G
Hspa8
heat shock protein family A (Hsp70) member 8
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
susceptibility
ISO
RGD
PMID:22264792
RGD:13838741
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Jak1
Janus kinase 1
ISO
mRNA:decreased expression:pancreatic ductal cell (human)
RGD
PMID:28677798
RGD:13838745
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:115,780,248...115,888,926
G
Mapk8
mitogen-activated protein kinase 8
severity disease_progression
ISO
protein:increased phosphorylation:pancreas (mouse)
RGD
PMID:28837246 PMID:23237571
RGD:14348974 , RGD:14348975
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mir155
microRNA 155
disease_progression
ISO
RGD
PMID:28198398
RGD:25314300
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir494
microRNA 494
disease_progression ameliorates
ISO
RGD
PMID:24859161 PMID:24859161
RGD:156430321 , RGD:156430321
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
G
Pgf
placental growth factor
severity
ISO
associated with obesity
RGD
PMID:26861455
RGD:14349030
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
ISO
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:20876794
RGD:14390130
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:48,766,864...48,802,043
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
severity
ISO
human cells in a mouse model
RGD
PMID:15591514
RGD:14390084
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,665,457...18,674,065
G
Pld1
phospholipase D1
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:27713167
RGD:14392801
NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:110,893,608...111,047,692
G
Ptprb
protein tyrosine phosphatase, receptor type, B
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
G
Ptprm
protein tyrosine phosphatase, receptor type, M
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 9:106,639,573...107,343,698
Ensembl chr 9:106,639,573...107,343,698
G
Rac1
Rac family small GTPase 1
ISO
mRNA:increased expression:pancreas (human) mRNA, protein:increased expression:pancreas (mouse)
RGD
PMID:23334332 PMID:21684285
RGD:14392806 , RGD:14392816
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:11,036,698...11,057,251
G
Rala
RAS like proto-oncogene A
ISO
mRNA:increased expression:pancreas (human)
RGD
PMID:29113235
RGD:14394418
NCBI chr17:51,787,682...51,840,738
Ensembl chr17:47,092,207...47,144,063
G
S100a8
S100 calcium binding protein A8
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
Smad2
SMAD family member 2
severity
ISO
RGD
PMID:26908446
RGD:14394493
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:69,850,377...69,912,323
G
Tgfb1
transforming growth factor, beta 1
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb2
transforming growth factor, beta 2
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
G
Tgfb3
transforming growth factor, beta 3
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:105,704,236...105,726,564
G
Tgfbr1
transforming growth factor, beta receptor 1
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:17297450
RGD:155630637
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:61,653,233...61,710,777
G
Vegfd
vascular endothelial growth factor D
ISO
protein:increased expression:blood serum (human)
RGD
PMID:21410412
RGD:155630646
NCBI chr X:33,704,582...33,740,305
Ensembl chr X:30,074,163...30,108,295
G
Vnn1
vanin 1
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all